IMOS $1.40 + $.167 $250 MM annual EBITDA IMOS is next RAS and KFN. $150 MM annual free cash flow $250 MM EBITDA, 77 MM shares OS. Huge depreciation charges skewing GAAP numbers but stocks valiued on cash flow. $15 target.